|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 1952 for Cdkn2a

0.043s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Wang P
Year: 2006
Journal: Oncogene
Title: Decreased Mdm2 expression inhibits tumor development induced by loss of ARF.
Volume: 25
Issue: 26
Pages: 3708-18
Publication
First Author: Volanakis EJ
Year: 2013
Journal: Exp Hematol
Title: Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.
Volume: 41
Issue: 4
Pages: 377-86
Publication
First Author: Kamijo T
Year: 1999
Journal: Cancer Res
Title: Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Volume: 59
Issue: 10
Pages: 2464-9
Publication
First Author: Treanor LM
Year: 2014
Journal: J Exp Med
Title: Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Volume: 211
Issue: 4
Pages: 701-13
Publication
First Author: Forys JT
Year: 2014
Journal: Cell Rep
Title: ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.
Volume: 7
Issue: 2
Pages: 514-26
Publication
First Author: Li C
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells.
Volume: 110
Issue: 12
Pages: E1112-21
Publication
First Author: Stepanova L
Year: 2005
Journal: Blood
Title: A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress.
Volume: 106
Issue: 3
Pages: 827-32
Publication
First Author: Helmrich A
Year: 2005
Journal: Oncogene
Title: Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.
Volume: 24
Issue: 26
Pages: 4174-82
Publication
First Author: Park HJ
Year: 2011
Journal: EMBO Mol Med
Title: Deregulation of FoxM1b leads to tumour metastasis.
Volume: 3
Issue: 1
Pages: 21-34
Publication
First Author: Kopanja D
Year: 2018
Journal: Carcinogenesis
Title: p19Arf inhibits aggressive progression of H-ras-driven hepatocellular carcinoma.
Volume: 39
Issue: 3
Pages: 318-326
Publication
First Author: Bertwistle D
Year: 2007
Journal: Blood
Title: Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Volume: 109
Issue: 2
Pages: 792-4
Publication
First Author: Volk EL
Year: 2009
Journal: Mol Cancer Res
Title: The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
Volume: 7
Issue: 6
Pages: 863-9
Publication
First Author: Vijayachandra K
Year: 2009
Journal: Mol Carcinog
Title: Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Volume: 48
Issue: 3
Pages: 181-186
Publication
First Author: Sorrentino JA
Year: 2014
Journal: J Clin Invest
Title: p16INK4a reporter mice reveal age-promoting effects of environmental toxicants.
Volume: 124
Issue: 1
Pages: 169-73
Publication
First Author: Molofsky AV
Year: 2005
Journal: Genes Dev
Title: Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.
Volume: 19
Issue: 12
Pages: 1432-7
Publication
First Author: Wigle JT
Year: 2002
Journal: EMBO J
Title: An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.
Volume: 21
Issue: 7
Pages: 1505-13
Publication
First Author: Baker DJ
Year: 2008
Journal: Nat Cell Biol
Title: Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.
Volume: 10
Issue: 7
Pages: 825-36
Publication
First Author: Hidalgo I
Year: 2012
Journal: Cell Stem Cell
Title: Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.
Volume: 11
Issue: 5
Pages: 649-62
Publication
First Author: Tu Q
Year: 2018
Journal: Oncogene
Title: CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.
Volume: 37
Issue: 1
Pages: 128-138
Publication
First Author: Ulanet DB
Year: 2010
Journal: PLoS One
Title: Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.
Volume: 5
Issue: 8
Pages: e12454
Publication
First Author: Eischen CM
Year: 2002
Journal: Cancer Res
Title: Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.
Volume: 62
Issue: 7
Pages: 2184-91
Publication
First Author: King D
Year: 2002
Journal: Oncogene
Title: Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
Volume: 21
Issue: 32
Pages: 4978-82
Publication
First Author: Ruddell A
Year: 2008
Journal: Oncogene
Title: p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Volume: 27
Issue: 22
Pages: 3145-55
Publication
First Author: Moore L
Year: 2003
Journal: Oncogene
Title: Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
Volume: 22
Issue: 49
Pages: 7831-7
Publication
First Author: Eischen CM
Year: 2004
Journal: Oncogene
Title: Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Volume: 23
Issue: 55
Pages: 8931-40
Publication
First Author: Gusarova GA
Year: 2007
Journal: J Clin Invest
Title: A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.
Volume: 117
Issue: 1
Pages: 99-111
Publication
First Author: Meng X
Year: 2016
Journal: Cancer Res
Title: RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Volume: 76
Issue: 17
Pages: 5030-9
Publication
First Author: Martin AC
Year: 2004
Journal: Invest Ophthalmol Vis Sci
Title: Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.
Volume: 45
Issue: 10
Pages: 3387-96
Publication
First Author: Cullion K
Year: 2009
Journal: Blood
Title: Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.
Volume: 113
Issue: 24
Pages: 6172-81
Publication
First Author: Ferletta M
Year: 2007
Journal: Mol Cancer Res
Title: Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Volume: 5
Issue: 9
Pages: 891-7
Publication
First Author: Zhang Y
Year: 2019
Journal: PLoS One
Title: Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL.
Volume: 14
Issue: 10
Pages: e0224172
Publication
First Author: Mikawa R
Year: 2018
Journal: Aging Cell
Title: Elimination of p19ARF -expressing cells protects against pulmonary emphysema in mice.
Volume: 17
Issue: 5
Pages: e12827
Publication  
First Author: Mikawa R
Year: 2020
Journal: Biomolecules
Title: p19Arf Exacerbates Cigarette Smoke-Induced Pulmonary Dysfunction.
Volume: 10
Issue: 3
Publication
First Author: Abdul-Aziz AM
Year: 2019
Journal: Blood
Title: Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
Volume: 133
Issue: 5
Pages: 446-456
Publication  
First Author: Kaur G
Year: 2021
Journal: Int J Mol Sci
Title: p16-3MR: A Novel Model to Study Cellular Senescence in Cigarette Smoke-Induced Lung Injuries.
Volume: 22
Issue: 9
Publication
First Author: Matheu A
Year: 2007
Journal: Nature
Title: Delayed ageing through damage protection by the Arf/p53 pathway.
Volume: 448
Issue: 7151
Pages: 375-9
Publication
First Author: Shields BJ
Year: 2016
Journal: Genes Dev
Title: Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a.
Volume: 30
Issue: 1
Pages: 78-91
Publication
First Author: Park J
Year: 2021
Journal: Dev Cell
Title: Progenitor-like characteristics in a subgroup of UCP1+ cells within white adipose tissue.
Volume: 56
Issue: 7
Pages: 985-999.e4
Publication
First Author: Lessard F
Year: 2010
Journal: Mol Cell
Title: The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I.
Volume: 38
Issue: 4
Pages: 539-50
Publication
First Author: Miceli AP
Year: 2012
Journal: Mol Cell Biol
Title: Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.
Volume: 32
Issue: 2
Pages: 348-64
Publication
First Author: Eischen CM
Year: 2012
Journal: PLoS One
Title: Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.
Volume: 7
Issue: 9
Pages: e46148
Publication
First Author: Eischen CM
Year: 1999
Journal: Genes Dev
Title: Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Volume: 13
Issue: 20
Pages: 2658-69
Publication
First Author: Weber JD
Year: 2000
Journal: Genes Dev
Title: p53-independent functions of the p19(ARF) tumor suppressor.
Volume: 14
Issue: 18
Pages: 2358-65
Publication
First Author: Matheu A
Year: 2005
Journal: J Biol Chem
Title: Regulation of the INK4a/ARF locus by histone deacetylase inhibitors.
Volume: 280
Issue: 51
Pages: 42433-41
Publication
First Author: Chen D
Year: 2013
Journal: Mol Cell
Title: Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.
Volume: 51
Issue: 1
Pages: 46-56
Publication
First Author: Tsai KY
Year: 2002
Journal: Curr Biol
Title: ARF is not required for apoptosis in Rb mutant mouse embryos.
Volume: 12
Issue: 2
Pages: 159-63
Publication
First Author: Eischen CM
Year: 2001
Journal: Mol Cell Biol
Title: Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Volume: 21
Issue: 22
Pages: 7653-62
Publication
First Author: Kelly-Spratt KS
Year: 2004
Journal: PLoS Biol
Title: p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Volume: 2
Issue: 8
Pages: E242
Publication
First Author: Marshall AD
Year: 2011
Journal: Cancer Res
Title: PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis.
Volume: 71
Issue: 24
Pages: 7471-80
Publication    
First Author: Morena D
Year: 2016
Journal: Elife
Title: Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.
Volume: 5
Publication  
First Author: Muralidharan SV
Year: 2020
Journal: Life Sci Alliance
Title: Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells.
Volume: 3
Issue: 8
Publication
First Author: Jacobsen JA
Year: 2017
Journal: J Immunol
Title: EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints.
Volume: 198
Issue: 12
Pages: 4682-4691
Publication
First Author: Konstantinidou G
Year: 2013
Journal: Cancer Discov
Title: RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas.
Volume: 3
Issue: 4
Pages: 444-57
Publication
First Author: Ozawa T
Year: 2014
Journal: Cancer Cell
Title: Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.
Volume: 26
Issue: 2
Pages: 288-300
Publication
First Author: Wu R
Year: 2023
Journal: Nat Commun
Title: Genetically prolonged beige fat in male mice confers long-lasting metabolic health.
Volume: 14
Issue: 1
Pages: 2731
Publication
First Author: Menges CW
Year: 2014
Journal: Cancer Res
Title: Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
Volume: 74
Issue: 4
Pages: 1261-1271
Publication
First Author: Moreno-Asso A
Year: 2013
Journal: Diabetologia
Title: Glucose regulation of a cell cycle gene module is selectively lost in mouse pancreatic islets during ageing.
Volume: 56
Issue: 8
Pages: 1761-72
Publication
First Author: Lund AH
Year: 2002
Journal: Nat Genet
Title: Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.
Volume: 32
Issue: 1
Pages: 160-5
Publication
First Author: An S
Year: 2015
Journal: Mol Med Rep
Title: Inactivation of INK4a and ARF induces myocardial proliferation and improves cardiac repair following ischemia‑reperfusion.
Volume: 12
Issue: 4
Pages: 5911-6
Publication
First Author: Wouters K
Year: 2012
Journal: PLoS One
Title: Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development.
Volume: 7
Issue: 3
Pages: e32440
Publication
First Author: Zhang SL
Year: 2001
Journal: Mol Cell Biol
Title: Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Volume: 21
Issue: 1
Pages: 310-8
Publication
First Author: Lin WC
Year: 2013
Journal: Cancer Res
Title: Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer.
Volume: 73
Issue: 6
Pages: 1821-30
Publication
First Author: Ahmad I
Year: 2017
Journal: Exp Dermatol
Title: Loss of INK4a/Arf gene enhances ultraviolet radiation-induced cutaneous tumor development.
Volume: 26
Issue: 11
Pages: 1018-1025
Publication
First Author: Krimpenfort P
Year: 2001
Journal: Nature
Title: Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
Volume: 413
Issue: 6851
Pages: 83-6
Publication
First Author: Deleye Y
Year: 2020
Journal: J Biol Chem
Title: CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
Volume: 295
Issue: 50
Pages: 17310-17322
Publication
First Author: Cudejko C
Year: 2011
Journal: Blood
Title: p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.
Volume: 118
Issue: 9
Pages: 2556-66
Publication  
First Author: Montano E
Year: 2021
Journal: Biomolecules
Title: Pancreatic Progenitor Commitment Is Marked by an Increase in Ink4a/Arf Expression.
Volume: 11
Issue: 8
Publication
First Author: González-Navarro H
Year: 2010
Journal: J Am Coll Cardiol
Title: p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.
Volume: 55
Issue: 20
Pages: 2258-68
Publication
First Author: Saito M
Year: 2019
Journal: J Invest Dermatol
Title: A Polymorphic Variant in p19Arf Confers Resistance to Chemically Induced Skin Tumors by Activating the p53 Pathway.
Volume: 139
Issue: 7
Pages: 1459-1469
Publication
First Author: Strauss RP
Year: 2020
Journal: Gene Expr
Title: Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in Hepatocarcinogenesis.
Volume: 20
Issue: 1
Pages: 39-52
Publication
First Author: Bouchard C
Year: 2007
Journal: Genes Dev
Title: FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
Volume: 21
Issue: 21
Pages: 2775-87
Publication
First Author: Guo Y
Year: 2011
Journal: Eur J Immunol
Title: Polycomb group gene Bmi1 plays a role in the growth of thymic epithelial cells.
Volume: 41
Issue: 4
Pages: 1098-107
Publication
First Author: Eischen CM
Year: 2001
Journal: Mol Cell Biol
Title: Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
Volume: 21
Issue: 15
Pages: 5063-70
Publication
First Author: Uren AG
Year: 2008
Journal: Cell
Title: Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.
Volume: 133
Issue: 4
Pages: 727-41
Publication
First Author: Debies MT
Year: 2008
Journal: J Clin Invest
Title: Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss.
Volume: 118
Issue: 1
Pages: 51-63
Publication
First Author: Shank-Calvo JA
Year: 2006
Journal: Oncogene
Title: p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
Volume: 25
Issue: 21
Pages: 3023-31
Publication
First Author: Tonelli C
Year: 2017
Journal: Oncogene
Title: Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas.
Volume: 36
Issue: 21
Pages: 2921-2929
Publication
First Author: Silva RL
Year: 2005
Journal: EMBO J
Title: Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.
Volume: 24
Issue: 15
Pages: 2803-14
Publication
First Author: Meng X
Year: 2015
Journal: Oncogene
Title: Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Volume: 34
Issue: 46
Pages: 5709-17
Publication
First Author: Bulavin DV
Year: 2004
Journal: Nat Genet
Title: Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.
Volume: 36
Issue: 4
Pages: 343-50
Publication
First Author: Chiacchiera F
Year: 2016
Journal: Cell Stem Cell
Title: Polycomb Complex PRC1 Preserves Intestinal Stem Cell Identity by Sustaining Wnt/β-Catenin Transcriptional Activity.
Volume: 18
Issue: 1
Pages: 91-103
Publication
First Author: Damsky W
Year: 2015
Journal: Cancer Cell
Title: mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Volume: 27
Issue: 1
Pages: 41-56
Publication
First Author: Diersch S
Year: 2016
Journal: Oncogene
Title: Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.
Volume: 35
Issue: 29
Pages: 3880-6
Publication
First Author: Li F
Year: 2018
Journal: Nat Commun
Title: Ezh2 programs TFH differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf.
Volume: 9
Issue: 1
Pages: 5452
Publication
First Author: Danis E
Year: 2015
Journal: Exp Hematol
Title: Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
Volume: 43
Issue: 11
Pages: 930-935.e6
Publication    
First Author: Reinitz F
Year: 2022
Journal: Elife
Title: Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer's model.
Volume: 11
Publication
First Author: Schuster K
Year: 2014
Journal: Mol Cancer Res
Title: Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis.
Volume: 12
Issue: 6
Pages: 912-23
Publication
First Author: Malumbres M
Year: 1998
Journal: Mamm Genome
Title: An AC-repeat adjacent to mouse Cdkn2B allows the detection of specific allelic losses in the p15INK4b and p16INK4a tumor suppressor genes.
Volume: 9
Issue: 3
Pages: 183-5
Publication
First Author: Põlajeva J
Year: 2011
Journal: PLoS One
Title: Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.
Volume: 6
Issue: 9
Pages: e25222
Publication
First Author: Charles N
Year: 2010
Journal: Cell Stem Cell
Title: Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.
Volume: 6
Issue: 2
Pages: 141-52
Publication
First Author: Uhrbom L
Year: 2005
Journal: Cancer Res
Title: Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Volume: 65
Issue: 6
Pages: 2065-9
Publication
First Author: Martinelli P
Year: 2011
Journal: Blood
Title: The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.
Volume: 117
Issue: 24
Pages: 6617-26
Publication
First Author: Mainwaring OJ
Year: 2023
Journal: Nat Commun
Title: ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Volume: 14
Issue: 1
Pages: 1221
Publication
First Author: Grosse L
Year: 2020
Journal: Cell Metab
Title: Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan.
Volume: 32
Issue: 1
Pages: 87-99.e6
Publication
First Author: Omori S
Year: 2020
Journal: Cell Metab
Title: Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo.
Volume: 32
Issue: 5
Pages: 814-828.e6
Publication
First Author: Jiang Y
Year: 2017
Journal: Cell Rep
Title: Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Volume: 18
Issue: 4
Pages: 977-990
Publication
First Author: Johnson RA
Year: 2010
Journal: Nature
Title: Cross-species genomics matches driver mutations and cell compartments to model ependymoma.
Volume: 466
Issue: 7306
Pages: 632-6
Publication
First Author: Zhang Z
Year: 2002
Journal: Oncogene
Title: A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.
Volume: 21
Issue: 38
Pages: 5960-6
Publication  
First Author: Liu XS
Year: 2015
Journal: Nat Commun
Title: LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair.
Volume: 6
Pages: 8325
Publication
First Author: Tsai KY
Year: 2002
Journal: Proc Natl Acad Sci U S A
Title: ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Volume: 99
Issue: 26
Pages: 16865-70